Core Laboratories N.V. (CLB) 의 후행 P/E는 24.7, 선행 P/E 21.6. 후행 이익수익률은 4.04%, 선행 이익수익률 4.64%. PEG 8.24. 그레이엄 넘버는 $9.62.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 62/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 81.7 | -1.76 | 33.61 | 8.78 | 1.82% |
| 2017 | 58.2 | 1.96 | 32.52 | 7.33 | 2.01% |
| 2018 | 33.2 | -7.79 | 16.39 | 3.76 | 3.69% |
| 2019 | 16.4 | 0.95 | 9.39 | 2.50 | 5.84% |
| 2020 | -12.1 | 0.06 | 16.49 | 2.42 | 1.06% |
| 2021 | 52.0 | -0.43 | 6.56 | 2.18 | 0.18% |
| 2022 | 48.3 | -20.76 | 5.10 | 1.92 | 0.20% |
| 2023 | 22.5 | 0.26 | 3.67 | 1.62 | 0.23% |
| 2024 | 25.9 | -1.70 | 3.22 | 1.55 | 0.23% |
| 2025 | 23.4 | 15.70 | 2.66 | 1.42 | 0.25% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $1.45 | $594.74M | $63.9M | 10.7% |
| 2017 | $1.88 | $659.81M | $83.13M | 12.6% |
| 2018 | $1.79 | $700.85M | $79.53M | 11.3% |
| 2019 | $2.10 | $668.21M | $101.98M | 15.3% |
| 2020 | $-2.16 | $487.27M | $-97.07M | -19.9% |
| 2021 | $0.50 | $470.25M | $19.73M | 4.2% |
| 2022 | $0.42 | $489.74M | $19.45M | 4% |
| 2023 | $0.77 | $509.79M | $36.68M | 7.2% |
| 2024 | $0.66 | $523.85M | $31.4M | 6% |
| 2025 | $0.68 | $526.52M | $31.8M | 6% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $0.73 | $0.71 – $0.74 | $516.88M | $516.16M – $517.61M | 1 |
| 2027 | $0.82 | $0.82 – $0.82 | $523.88M | $523.15M – $524.61M | 1 |
| 2028 | $1.48 | $1.48 – $1.48 | $623M | $622.13M – $623.87M | 1 |
